{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:05:28Z","timestamp":1790629528038,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.critrevonc.2008.12.010","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T09:43:25Z","timestamp":1233222205000},"page":"233-241","source":"Crossref","is-referenced-by-count":29,"title":["Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: Results from the SOCRATES retrospective study"],"prefix":"10.1016","volume":"71","author":[{"given":"Sandro","family":"Pignata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Ferrandina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Scarfone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Scollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Odicino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Cormio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionyssios","family":"Katsaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Frigerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Mereu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Manzione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Lauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Breda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiderio Gueli","family":"Alletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Ballardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Vernaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Tumolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Musso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Magni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2008.12.010_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","article-title":"Cancer statistics 2002","volume":"52","author":"Jemal","year":"2002","journal-title":"Ca Cancer J Clin"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00130404-200511000-00002","article-title":"Population aging and cancer: a cross-national concern","volume":"11","author":"Yancik","year":"2005","journal-title":"Cancer J"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0959-8049(92)90153-S","article-title":"Trends of cancer mortality in Europe 1955\u201389: breast and genital sites","volume":"28","author":"La Vecchia","year":"1992","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2008.12.010_bib4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1470-2045(07)70246-2","article-title":"EUROCARE-4 Working Group Recent cancer survival in Europe: a 2000\u201302 period analysis of EUROCARE-4 data","volume":"8","author":"Verdecchia","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/1097-0142(19940115)73:2<377::AID-CNCR2820730223>3.0.CO;2-#","article-title":"National survey of ovarian carcinoma IV: patterns of care and related survival for older patients","volume":"73","author":"Hightower","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/gyno.1995.1184","article-title":"Rising ovarian cancer mortality in the elderly: a manifestation of differential survival","volume":"58","author":"Riggs","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ygyno.2005.04.037","article-title":"Treatment patterns by decade of life in elderly women (\u226570 years of age) with ovarian cancer","volume":"98","author":"Uyar","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0959-8049(00)00050-2","article-title":"Single agents should be administered in preference to combination chemotherapy for the treatment of patients over 70 years of age with advanced ovarian cancer","volume":"36","author":"Pignata","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1040-8428(03)00100-8","article-title":"Ovarian cancer in the elderly","volume":"49","author":"Pignata","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with placlitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/jnci\/92.9.699","article-title":"Randomized intergroup trial of cisplatin\u2013paclitaxel versus cisplatin\u2013cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results","volume":"92","author":"Piccart","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib12","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"Arbeitsgemeinschaft Gynakologische Onkologie Ovarian Cancer Study Group: a randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer","volume":"95","author":"du Bois","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0029-7844(98)00334-2","article-title":"Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings","volume":"93","author":"Rubin","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"9375","key":"10.1016\/j.critrevonc.2008.12.010_bib14","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"ICON and AGO Collaborators. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"Parmar","year":"2003","journal-title":"Lancet"},{"issue":"29","key":"10.1016\/j.critrevonc.2008.12.010_bib15","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1200\/JCO.2006.06.0913","article-title":"AGO-OVAR; NCIC CTG; EORTC GCG. Gemcitabine\/carboplatin (GC) vs. carboplatin (C) in platinum sensitive recurrent ovarian cancer (OVCA)","volume":"24","author":"Pfisterer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1996.14.5.1545","article-title":"Defining response of ovarian carcinoma to initial chemotherapy according to serum Ca 125","volume":"14","author":"Rustin","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"issue":"Suppl. 8","key":"10.1016\/j.critrevonc.2008.12.010_bib19","doi-asserted-by":"crossref","first-page":"viii7","DOI":"10.1093\/annonc\/mdi961","article-title":"Gynecologic Cancer Intergroup; AGO-OVAR; ANZGOG; EORTC; GEICO; GINECO; GOG; JGOG; MRC\/NCRI; NCIC-CTG; NCI-US; NSGO; RTOG; SGCTG; IGCS; Organizational team of the two prior International OCCC: 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)","volume":"16","author":"du Bois","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.1991.9.3.389","article-title":"Second-line platinum-therapy in patients with ovarian cancer previously treated with cisplatin","volume":"9","author":"Markman","year":"1991","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.critrevonc.2008.12.010_bib21","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Committee; AGO Ovarian Cancer Study Group Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib22","first-page":"379","article-title":"Surgical treatment of the elderly patient with gynecologic cancer","volume":"170","author":"Kirschner","year":"1990","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib23","first-page":"287","article-title":"Surgery for invasive gynaecologic cancer in the elderly female population","volume":"76","author":"Lawton","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/gyno.1999.5591","article-title":"Gynecologic oncologic surgery in the elderly: a retrospective analysis of 213 patients","volume":"75","author":"Susini","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib25","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ajog.2004.01.078","article-title":"Morbidity of cytoreductive surgery in the elderly","volume":"190","author":"Wright","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib26","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.ajog.2005.06.074","article-title":"Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients","volume":"193","author":"Sharma","year":"2005","journal-title":"Am J Obstet gynecol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1200\/JCO.20.1.173","article-title":"Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study","volume":"20","author":"Sundararajan","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0889-8588(05)70284-7","article-title":"Antineoplastic chemotherapy of the older cancer patient","volume":"144","author":"Balducci","year":"2000","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/107327489900600504","article-title":"Pharmacology of chemotherapy in the older cancer patient","volume":"6","author":"Balducci","year":"1999","journal-title":"Cancer Control"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib30","first-page":"3","article-title":"Age-related declines in hematopoietic reserve capacity","volume":"22","author":"Lipschitz","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<395::AID-CNCR24>3.0.CO;2-W","article-title":"Validation of a multidimensional evaluation scale for use in elderly cancer patients","volume":"77","author":"Monfardini","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1200\/JCO.20.2.494","article-title":"Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study","volume":"20","author":"Repetto","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2005.06.003","article-title":"Task Force on CGA of the International Society of Geriatric Oncology. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)","volume":"55","author":"Extermann","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1006\/gyno.2002.6631","article-title":"Gynecological malignancies in elderly patients is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study","volume":"85","author":"Ceccaroni","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1179\/joc.2007.19.5.577","article-title":"Gemcitabine combined with oxaliplatin (GEMOX) as salvage treatment in elderly patients with advanced ovarian cancer refractory or resistant to platinum: a single institution experience","volume":"19","author":"Germano","year":"2007","journal-title":"J Chemother"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib36","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/annonc\/mdi368","article-title":"Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study","volume":"16","author":"Freyer","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.010_bib37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/annonc\/mdl400","article-title":"Carboplatin\/cyclophospamyde or carboplatin\/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d\u2019Investigateurs Nationaux pour l\u2019etude des cancer ovariens","volume":"18","author":"Tr\u00e9dan","year":"2007","journal-title":"Ann Oncol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808003090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808003090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T08:38:19Z","timestamp":1738917499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842808003090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1040842808003090"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2008.12.010","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}